Ocular Evidence
Community experiences

What people report after refractive surgery

Search structured details from individual public forum accounts. These are anecdotes, not clinical evidence or estimates of how often an outcome occurs.

Read this layer differently from study results. Posts are self-reported, selectively shared and may be incomplete or inaccurate. We never combine them into complication, satisfaction or success rates.
Reset

202 reviewed experiences

Only curator-approved records with a currently verified source appear here. No usernames or copied post bodies are published.

Self-reported anecdoteMixed report

ICL experience · 2025

A first-person ICL account at 3 weeks described the result. The source included baseline prescription values. Topics included dry eye, halos, blur or fluctuating vision, floaters. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Reported prescription values-9.5 D, -10 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 3 weeks · stated by poster
Symptoms discusseddry eye, halos, blur or fluctuating vision, floaters
Both eyes · 3 weeks · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20. The poster's overall assessment was favorable.

Age
33

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 10 months described the result. Reported acuity included 20/20, 12/10, 10/10. Topics included dry eye, halos, pain or discomfort. The poster's overall assessment was favorable.

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 10 months · stated by poster
Reported visual-acuity values20/20, 12/10, 10/10
10 months · stated by poster
Symptoms discusseddry eye, halos, pain or discomfort
Both eyes · 10 months · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2025

A first-person ICL account at 6 weeks described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included dry eye, blur or fluctuating vision. The source did not state a clear overall satisfaction judgment.

Device
EVO ICL

Reported starting point

Reported prescription values-6.75 D, -1 D, -6 D, -1.75 D
stated by poster
Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 6 weeks · stated by poster
Reported visual-acuity values20/20, 20/15
6 weeks · stated by poster
Symptoms discusseddry eye, blur or fluctuating vision
Both eyes · 6 weeks · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/30. Topics included dry eye, halos, starbursts, double vision. The poster's overall assessment was favorable.

Clinic
Maloney-Shamie-Hura Institute
Device
EVO ICL

Reported starting point

Reported prescription values-6 D, -7 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/30
Follow-up reported · stated by poster
Symptoms discusseddry eye, halos, starbursts, double vision, blur or fluctuating vision, light sensitivity, night-vision difficulty, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2025

A first-person ICL account at 1 week described the result. Topics included halos, double vision, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 week · stated by poster
Symptoms discussedhalos, double vision, pain or discomfort
Both eyes · 1 week · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/25, 20/30, 20/15. Topics included halos, blur or fluctuating vision, haze. The poster's overall assessment was favorable.

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/25, 20/30, 20/15
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, haze
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Age
31
Device
EVO ICL

Reported starting point

Reported prescription values-6 D, -2 D, -5.25 D, -2.25 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedlight sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/15, 20/20. Topics included blur or fluctuating vision, haze, pain or discomfort. The poster's overall assessment was favorable.

Age
25

Reported starting point

Reported prescription values-6 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/15, 20/20
Follow-up reported · stated by poster
Symptoms discussedblur or fluctuating vision, haze, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included halos, double vision, light sensitivity, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Reported prescription values-10 D, -9 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedhalos, double vision, light sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 3 days described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included dry eye, halos, glare, ghosting. The poster's overall assessment was favorable.

Age
29
Clinic
Herzig Institute
Device
EVO ICL

Reported starting point

Reported prescription values-4 D, -3.5 D, -1.75 D, -2.75 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 3 days · stated by poster
Reported visual-acuity values20/20, 20/15
3 days · stated by poster
Symptoms discusseddry eye, halos, glare, ghosting, haze, light sensitivity
Both eyes · 3 days · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 1 week described the result. The source included baseline prescription values. Reported acuity included 6/30, 20/100, 20/25, 20/30. Topics included starbursts, glare, blur or fluctuating vision, night-vision difficulty. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-6 D, -8 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 week · stated by poster
Reported visual-acuity values6/30, 20/100, 20/25, 20/30
1 week · stated by poster
Symptoms discussedstarbursts, glare, blur or fluctuating vision, night-vision difficulty, pain or discomfort
Both eyes · 1 week · stated by poster
Self-reported anecdoteReported dissatisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included dry eye. The poster's overall assessment was unfavorable.

Reported starting point

Reported prescription values-3.75 D, +1 D
stated by poster
Overall self-assessmentunsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discusseddry eye
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20, 20/100, 20/15, 20/10. Topics included halos, light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/100, 20/15, 20/10
Follow-up reported · stated by poster
Symptoms discussedhalos, light sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/40, 20/30. Topics included dry eye, halos, starbursts, glare. The poster's overall assessment was favorable.

Clinic
Brinton Vision
Device
EVO ICL

Reported starting point

Reported prescription values-10 D, -10.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/40, 20/30
Follow-up reported · stated by poster
Symptoms discusseddry eye, halos, starbursts, glare, ghosting, blur or fluctuating vision, light sensitivity, night-vision difficulty
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.

Age
41

Reported starting point

Reported prescription values-1 D, -0.75 D, -5 D, -4 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedblur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-7.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedlight sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

Six months after ICL, the poster reported roughly 20/20 vision without complications and described the result very positively. The main difficulty reported was anxiety before surgery rather than postoperative visual symptoms.

Age
39
Location
United States

Reported starting point

Sphere-8 D
stated by poster
Sphere-5 D
stated by poster

Reported results and symptoms

Visual acuityApproximately 20/20
Both eyes · 6 months · stated by poster
ComplicationsNone reported
Both eyes · 6 months · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 9 days described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included dry eye, halos, starbursts, glare. The poster's overall assessment was favorable.

Age
27
Device
EVO ICL

Reported starting point

Reported prescription values-4.5 D, -5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 9 days · stated by poster
Reported visual-acuity values20/20, 20/15
9 days · stated by poster
Symptoms discusseddry eye, halos, starbursts, glare, ghosting, blur or fluctuating vision, light sensitivity, pain or discomfort
Both eyes · 9 days · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 10 months described the result. The source included baseline prescription values. Topics included halos, ghosting, haze. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-5.5 D, -1 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 10 months · stated by poster
Symptoms discussedhalos, ghosting, haze
Both eyes · 10 months · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 1 month described the result. The source included baseline prescription values. Reported acuity included 6/6. Topics included dry eye. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-3.75 D, -4.25 D, -5.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 month · stated by poster
Reported visual-acuity values6/6
1 month · stated by poster
Symptoms discusseddry eye
Both eyes · 1 month · stated by poster
Self-reported anecdoteReported dissatisfied

ICL experience · 2025

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/10. Topics included dry eye, halos, glare, double vision. The poster's overall assessment was unfavorable.

Reported starting point

Reported prescription values-7 D, -6.5 D, -7.5 D, -7.25 D
stated by poster
Overall self-assessmentunsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/10
Follow-up reported · stated by poster
Symptoms discusseddry eye, halos, glare, double vision, blur or fluctuating vision, pain or discomfort, regression
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2024

A first-person ICL account at 1 year described the result. Reported acuity included 20/20. Topics included dry eye, halos, blur or fluctuating vision. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 year · stated by poster
Reported visual-acuity values20/20
1 year · stated by poster
Symptoms discusseddry eye, halos, blur or fluctuating vision
Both eyes · 1 year · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2025

A first-person ICL account at 1 week described the result. Reported acuity included 20/50, 20/30, 20/60, 20/25. Topics included dry eye, halos, blur or fluctuating vision. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 week · stated by poster
Reported visual-acuity values20/50, 20/30, 20/60, 20/25
1 week · stated by poster
Symptoms discusseddry eye, halos, blur or fluctuating vision
Both eyes · 1 week · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2025

A first-person ICL account at 2 weeks described the result. Topics included halos, blur or fluctuating vision, night-vision difficulty, pain or discomfort. The poster's overall assessment was favorable.

Age
26
Device
EVO ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 weeks · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, night-vision difficulty, pain or discomfort
Both eyes · 2 weeks · stated by poster